Inicio › Enfermedades de los pulmones › Florida
Ensayos clínicos de Enfermedades de los pulmones en Florida
26 estudios sobre Enfermedades de los pulmones buscan participantes en Florida.
Ciudades en Florida
- Miami10 estudios
- Orlando8 estudios
- Jacksonville7 estudios
- Tampa7 estudios
- Hialeah5 estudios
- Gainesville3 estudios
Texto oficial del estudio (inglés)
A Study of COVID-19 Vaccine(s) in Children and Adults
- C & R Research Servcies USA, Inc., Homestead
- Indago Research & Health Center, Inc, Miami Lakes
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 5 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07798648A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- BRP- Hialeah Hospital, Hialeah
- D&H Cancer Research Center LLC, Margate
- Kendall South Medical Center, Miami
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07013474A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Millennium Medical Research - Miami, Miami
- Deluxe Health Center, Miami Lakes
- Florida Institute For Clinical Research, LLC, Orlando
ReclutandoFase 2
Edades de 40 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07759245A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Innovative Research of West Florida, Clearwater
- Invictus Clinical Research Group, Coconut Creek
- Hillcrest Medical Research LLC, DeLand
- y 16 más
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06679140American Lung Association (ALA) Lung Health Cohort
- Nemours Children's Jacksonville, Jacksonville
- University of Florida, Jacksonville, Jacksonville
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 25 a 35 · Todos los sexos · Actualizado el 23 sept 2026 · NCT04543461Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Florida Cancer Specialists, Sarasota
- Moffitt Cancer Center and Research Institute, Tampa
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06128551A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
- Site 1009, Plantation
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07407933A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Millennium Oncology Research Clinic, Hollywood
- University of Florida - Jacksonville, Jacksonville
- Miami Cancer Institute at Baptist Health, Inc., Miami
- y 3 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06119581A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Gainesville
- GSK Investigational Site, Naples
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06572384Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Florida, Jacksonville
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07059091A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Kissimmee
ReclutandoFase 2
Edades de 18 a 85 · Todos los sexos · Actualizado el 2 sept 2026 · NCT07333183Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Gainesville
- Research Site, Jacksonville
- Research Site, Lakeland
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 ago 2026 · NCT05624450A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Miami
- Research Site, Pembroke Pines
- Research Site, Saint Cloud
ReclutandoFase 2
Edades de 4 a 11 · Todos los sexos · Actualizado el 27 ago 2026 · NCT07525375Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Sylvester Comprehensive Cancer Center Miami, Miami
- AdventHealth Cancer Institute, Orlando
- H Lee Moffitt Cancer Center and Research Institute, Tampa
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 ago 2026 · NCT06765109A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 103, Gainesville
- GC2501 Study Site 105, Miami
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 11 ago 2026 · NCT07555483A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
- Palm Springs Community Health Center, Miami Lakes
ReclutandoFase 4Se aceptan voluntarios sanos
Edades de 18 a 64 · Todos los sexos · Actualizado el 7 ago 2026 · NCT07730450Deep Functional Phenotyping of the ALA Lung Health Cohort
- Nemours Children's Jacksonville, Jacksonville
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 25 a 35 · Todos los sexos · Actualizado el 17 jul 2026 · NCT06177717Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- H Lee Moffitt Cancer Center and Research Institute, Tampa
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 26 jun 2026 · NCT04614103A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- Sylvester Comprehensive Cancer Center, Miami
- Orlando Health Cancer Institute, Orlando
- Moffitt Cancer Center, Tampa
ReclutandoFase 1/2
Edades de 18 a 70 · Todos los sexos · Actualizado el 11 jun 2026 · NCT05361174A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Memorial Healthcare System, Hollywood
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 27 may 2026 · NCT03093116Data Collection Using Eko Digital Devices in a Clinical Setting
- Nemours Children's Health, Jacksonville
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 26 may 2026 · NCT07227376Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
- University of Miami, Miami
ReclutandoEstudio observacional
Edades de 18 a 75 · Todos los sexos · Actualizado el 23 mar 2026 · NCT06494033Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Bay Pines VA Healthcare System, Pay Pines, FL, Bay Pines
- Miami VA Healthcare System, Miami, FL, Miami
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 feb 2026 · NCT02984761A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- AdventHealth Orlando, Orlando
- Moffitt Cancer Center, Tampa
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 dic 2025 · NCT06619561Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Florida Lung Asthma and Sleep Specialist, Celebration
- Central Florida Pulmonary Group, P.A. (CFPG) - Downtown Orlando, Orlando
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 12 nov 2025 · NCT05975983Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- University of Florida, Jacksonville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jul 2024 · NCT02735707De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.